Mapping Malaysia's Resource Centres

102 MAPPING MALAYSIA’S RESOURCE CENTRES DUOPHARMA BIOTECH BERHAD (DUOPHARMA) Area of Expertise 1. Generic pharmaceuticals Manufacturing. 2. Generic pharmaceuticals Research & Development. 3. Pioneer in Halal Pharmaceuticals. Strengths and Achievements Manufacturing facilities licensed by the National Pharmaceuticals Regulatory Authority (NPRA) Malaysia and fully compliant with Good Manufacturing Practice (GMP) guidelines of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and requirements of World Health Organisation (WHO) and Therapeutic Goods Administration Australia (TGA). Halal Certified by Department of Islamic Development Malaysia (JAKIM) and Lembaga Pengkajian Pangan Obat- obatan dan Kosmetika Majelis Ulama Indonesia (LPPOM MUI). Projects Undertaken (Domestic) 1. 2015 i. Small Volume Injectable (SVI) plant. ii. Joint Phase-3 clinical study for biosimilar in Malaysia and Korea. 2. 2017 Set up of effervescent manufacturing facility and Haemo plant for hemodialysis solution. 3. 2018 Installed Malaysia’s 1st biological pre-filled syringe line to manufacture biosimilar. 4. 2019 Completed and commissioned Malaysia’s first Highly Potent Active Pharmaceutical Ingredients facility for the production of oncology and psychotropic drugs. Projects Undertaken (International) Established partnerships with Natco (India), Biocon (India), Becton Dickinson, SCM Lifescience (Korea) and PanGen Biotech (Korea). Recognition and Awards 1. Halal Brand Excellence Award, Halal Industry Development Corporation, 2019. 2. Best Companies to Work for in Asia, HR Asia, 2018. 3. Flavettes; Champs; Naturalle, Watsons Health, Wellness & Beauty Awards, 2018. 4. Halal Pharmaceutical Company of the Year, Frost & Sullivan, 2018. 5. Malaysia Pharmaceutical Company of the Year in Generics category, Frost & Sullivan, 2018. 6. Champs, Malaysia Health & Wellness Brand Awards, 2017. 7. Halal Pharmaceutical Company of the Year in Prescription H E A L T H C A R E A N D P H A R M A C E U T I C A L Introduction Duopharma Biotech was incorporated in the year 2000 and is today one of Malaysia’s leading pharmaceutical companies listed on the Main Market of Bursa Malaysia Berhad. Duopharma Biotech has core competencies in the pharmaceutical industry which includes Manufacturing, Research & Development and Commercialisation & Marketing of over 300 generic drugs and consumer healthcare products such as Omesec, Prelica, CHAMPS®, FLAVETTES®, PROVITON® and Uphamol, which are well- recognised and accepted by consumers in Malaysia, regionally and globally. The Company has also diversified into the biosimilars space with technology and commercialisation collaborations with credible and strong international partners. Duopharma Biotech owns and operates three manufacturing plants that are based in Klang, Bangi and Glenmarie, Selangor with subsidiary and representative offices in Indonesia, the Philippines and Singapore.